Real-time enrollment status for this kidney disease clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 12:29 AM UTC
| NCT Number | NCT06824987 |
| Recruiting Status | Recruiting |
| Condition | Kidney Disease |
| Phase | PHASE2 |
| Target Enrollment | 136 participants |
| Active Locations | 79 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 20, 2026: Clinical trial NCT06824987 is currently recruiting participants. This phase2 study for kidney disease is actively seeking new participants at 79 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06824987 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 79 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06824987 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.